Rockwell Automation Inc (NYSE: ROK), an industrial automation and digital transformation company, on Tuesday revealed the adoption of FactoryTalk PharmaSuite MES by Rottendorf Pharma GmbH. This comprehensive electronic batch recording solution promises increased accuracy, quality, efficiency and repeatability, laying the groundwork for future digitalisation endeavors. The deployment aims to optimise day-to-day metrics, multi-customer batch control, and global software validation.
Headquartered in Ennigerloh, Germany, Rottendorf Pharma operates as a global CDMO with expertise in solid-dosage-form production. Embracing Total Process Ownership (TPO) and Total Technological Mastering (TTM) philosophies, the company streamlines customer management, reduces costs and enhances supply chains and product quality.
The deployment of FactoryTalk PharmaSuite MES at Rottendorf Pharma extends beyond operational enhancements, providing consistent weigh-and-dispense data for central weighing operations. This marks the initial step in achieving end-to-end electronic batch recording throughout the pharma value chain.
Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs around 29,000 professionals across more than 100 countries.
Rottendorf Pharma, with over 95 years of experience, offers a diverse portfolio of original and generic drugs, backed by a workforce of over 1,300 experts.
CivicaScript launches droxidopa for symptomatic neurogenic orthostatic hypotension
Padagis' Naloxone HCl Nasal Spray 4 mg obtains extended shelf-life of 36 months
ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets
Newbury Pharmaceuticals secures approval for Macitentan in Denmark
Mallinckrodt and Endo to merge in USD6.7bn deal to create pharmaceutical leader
Genomma Lab Internacional announces quarterly dividend
Aveva Drug Delivery systems introduces generic Fentanyl Transdermal Patch in US
Independent Pharmacy Cooperative signs cooperation agreement with Legacy Pharmacy Group
ILIKOS Consulting partners with Jordan Center for Pharmaceutical Research
Axsome Therapeutics settles patent litigation with Teva over AUVELITY
Breckenridge Pharmaceutical's Everolimus Tablets for Oral Suspension receive US FDA approval
Newbury Pharmaceuticals secures generic approval for pomalidomide in Denmark
Newbury Pharmaceuticals secures generic approval for Bosutinib in Norway
Guangzhou Fermion Technology partners with Simcere Pharmaceutical